Partners
Partner with Prescryptive as we transform the U.S. prescription drug market
We’ve built the core infrastructure needed for a connected, transparent ecosystem that puts consumers first and gives them digital control over their prescriptions. If you’re ready to embrace that mission, you’ve found the right partner.
A more individualized experience for Transcarent members and their families
Confusing, complex and costly no more. By teaming up, Prescryptive and Transcarent are putting patients at the center of an improved pharmacy care experience.
Building community based on shared values with the NCPA
Partnering with Prescryptive helps the National Community Pharmacists Association (NCPA) imagine an AI-powered path into the future for independent pharmacies.
Challenging the traditional drug-pricing model in partnership with Eli Lilly and Company
Creating a new and first-to-market insulin subscription model helps stabilize costs for employers and increase utilization for diabetics reliant on employer-based care.
“Prescryptive AI Pricing does the hard work for us when it comes to setting our cash pricing.”
7
locations using Prescryptive AI Pricing to customize store’s positioning in market
Up to $4
average uplift per cash prescription over historic claims
13,000+
total cash prescriptions processed on Prescryptive AI Pricing as of Feb 2024
“AI pricing gives me confidence I’m not leaving money on the table.”
58%
revenue increase year to date
16%
revenue increase
Personalized data
analysis and insights
“[Costs are] 45% lower than when we started three years ago.”
45%
improvement in plan savings compared to the incumbent
30%
drop in PMPM costs for the plan in the months following Prescryptive’s implementation
Plan member
experience has exceeded all expectations
9.7/10
employer satisfaction rating with Prescryptive transition
9/10
members would feel disappointed without myPrescryptive
18%
reduction in formulary noncompliance
News & Insights
Chief Executive Officer Chris Blackley on the healthcare leadership operating system
“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…
GLP-1 pills are here: What does it mean for employers?
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn’t so straightforward.
As Ozempic costs fall, demand for weight-loss drugs is set to surge
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…
Direct access isn’t a program – it’s market design
Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.
Connect with us
Want to bring transparency to your prescription process? Get in touch to see how.